Clinical Trials Directory

Trials / Completed

CompletedNCT01653795

A Comparison of the Laryngeal Mask Airway (LMA) - Unique and LMA-Supreme in Children

A Randomized Trial Comparing the Laryngeal Mask Airway-Unique and Laryngeal Mask Airway-Supreme in Children

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
180 (actual)
Sponsor
Ann & Robert H Lurie Children's Hospital of Chicago · Academic / Other
Sex
All
Age
3 Months – 11 Years
Healthy volunteers
Accepted

Summary

The aim of this randomized prospective study is to compare two single-use laryngeal mask airways the LMA Unique and the LMA Supreme, in pediatric patients. The investigators hypothesize that airway leak pressures with the LMA Supreme will be superior to the LMA Unique.

Detailed description

The goal of this study is to compare the LMA Unique and LMA-Supreme in children undergoing anesthesia. The investigators hypothesize that airway leak pressures with the LMA Supreme will be superior when compared with the LMA Unique at two different standardized intracuff pressures (40 and 60 cm H20). Airway leak pressures will be measured by recording the circuit pressure at which equilibrium is reached. The ease of placement, fiberoptic grade of laryngeal view, feasibility of use, and complications will also be assessed.

Conditions

Interventions

TypeNameDescription
DEVICELMA Unique: control deviceLMA Unique will be placed in children based on a computer generated randomization. One of four different sizes of airways will be used: 1.5, 2.0, or 2.5. The size of the airway device will be determined according to the manufacturer's guidelines that are standardized by the patient's weight in kilograms.
DEVICELMA Supreme: comparison deviceLMA Supreme will be placed in children based on a computer generated randomization. One of four different sizes of airways will be used: 1.5, 2.0, or 2.5, The size of the airway device will be determined according to the manufacturer's guidelines that are standardized by the patient's weight in kilograms.

Timeline

Start date
2012-07-01
Primary completion
2012-11-01
Completion
2012-11-01
First posted
2012-07-31
Last updated
2012-11-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01653795. Inclusion in this directory is not an endorsement.